EssenMAFLDNCT07194863
Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 8 words Show 6 more changesShow less
- Primary endpoints: details revised at 1 of 1 entry
- Completed without a posted recruiting period
- Primary completion date changed from estimate of Nov 1, 2026 to Oct 1, 2026
- Study sites: 0 to 1
- Start date changed from estimate of Nov 1, 2026 to Oct 1, 2026
- Study description revised
- Notable Start date: Nov 1, 2025 to Nov 1, 2026
- Primary completion date: Sep 1, 2026 to Nov 1, 2026
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
evaluate the efficacy of Essential phospholipid versus Betaine HCL/L-Glutamic Acid in MAFLD
Timeframe: Baseline and at 12 weeks of treatment
Sites
1 site in 1 country
- Assiut UniversityAsyut, Egypt